|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 5/02/06 Paratek Pharmaceuticals, Inc. 8-A12G 1:17K RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: 8-A12G Registration of a Class of Securities HTML 18K
| Form 8-A12G |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Novacea, Inc.
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 33-0960223 | |
| (State of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
| 601 Gateway Boulevard, Suite 880 South San Francisco, California |
94080 | |
| (Address of Principal Executive Offices) | (Zip Code) |
| If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A. (c), please check the following box. ¨ | If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. x |
Securities Act registration statement file number to which this form relates: 333-131741
Securities to be registered pursuant to Section 12(b) of the Act:
| Title of Each Class to be so Registered |
Name of Each Exchange on Which Each Class is to be Registered | |
| None | None |
Securities to be registered pursuant to Section 12(g) of the Act:
| Common Stock, par value $0.001 | ||||
| (Title of Class) |
Item 1.
Description of Registrant’s Securities to be Registered.
The description of the Common Stock of Registrant set forth under the caption “Description of Capital Stock” in Registrant’s Registration Statement on Form S-1 (File No. 333-131741) originally filed with the Securities and Exchange Commission on February 10, 2006, as amended (the “Registration Statement”), and in the prospectus included in the Registration Statement, is hereby incorporated by reference in response to this item.
Item 2.
The following exhibits are filed herewith or are incorporated by reference as indicated below.
| Exhibit |
Description | |
| 3.3*** | Amended and Restated Certificate of Incorporation of Novacea, Inc. to be effective upon completion of this offering. | |
| 3.5*** | Amended and Restated Bylaws of Novacea, Inc. to be effective upon completion of this offering. | |
| 4.1** | Specimen Common Stock certificate of Novacea, Inc. | |
| 4.2* | 2005 Amended and Restated Investor Rights Agreement, dated as of December 21, 2005, by and between Novacea, Inc. and purchasers of Series A, Series B and Series C Preferred Stock. | |
| * | Incorporated by reference to the identically numbered exhibit to the Registration Statement on Form S-1 of Novacea, Inc. filed by Novacea, Inc. on February 10, 2006 (File No. 333-131741). |
| ** | Incorporated by reference to the identically numbered exhibit to Amendment No. 2 to the Registration Statement on Form S-1 of Novacea, Inc. filed by Novacea, Inc. on April 14, 2006 (File No. 333-131741). |
| *** | Incorporated by reference to the identically numbered exhibit to Amendment No. 3 to the Registration Statement on Form S-1 of Novacea, Inc. filed by Novacea, Inc. on May 2, 2006 (File No. 333-131741). |
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: May 2, 2006 | Novacea, Inc. | |||
| By: | ||||
| Bradford S. Goodwin | ||||
| Chief Executive Officer | ||||
| This ‘8-A12G’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/2/06 | S-1/A | ||
| 4/14/06 | S-1/A | |||
| 2/10/06 | S-1 | |||
| 12/21/05 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/09/23 Paratek Pharmaceuticals, Inc. S-3 6:1.4M Workiva Inc Wde… FA01/FA 5/17/21 Paratek Pharmaceuticals, Inc. 424B5 1:411K Donnelley … Solutions/FA |